Forty years of topical beta-blockers

28 February 2020
Volume 21, Issue 1

This article reviews the use of topical beta-blockers for the treatment of glaucoma.

Although beta-blockers are no longer first choice for the treatment for glaucoma, they maintain a place in the treatment pathway. This article reviews the history and contemporary use of topical beta-blockers, and considers the range of alternative medical, laser and minimally invasive surgical options for glaucoma.

Sign in to continue

Forgotten password?
Register

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

Primary care optometrists are moving beyond sight tests into delivering therapeutic eye care services and becoming the first port of call for eye health, writes Dr Paramdeep Bilkhu MCOptom.

The College has expanded its range of online courses, specialty independent prescribing CPD, webinars, peer reviews and Docet resources for 2026.

The consultation seeks views on extending the range of medicines available to optometrists and contact lens opticians.